{"id":47368,"date":"2022-12-21T12:50:55","date_gmt":"2022-12-21T10:50:55","guid":{"rendered":"https:\/\/newserver.fyb.de\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/"},"modified":"2022-12-21T12:50:55","modified_gmt":"2022-12-21T10:50:55","slug":"series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/","title":{"rendered":"Series\u2011D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical"},"content":{"rendered":"<div>\n<p>Landshut\/Munich \u2014 Bayern Kapi\u00adtal, one of the most expe\u00adri\u00aden\u00adced and active growth inves\u00adtors in the German high-tech land\u00adscape, is once again inves\u00adt\u00ading in iThera Medi\u00adcal with funds from the Bava\u00adrian Growth Fund. The Munich-based MedTech start-up is active in the field of optoa\u00adcou\u00adstic imaging for medi\u00adcal diagno\u00adstics and has deve\u00adlo\u00adped the laser light-based \u201cMSOT\u201d tech\u00adno\u00adlogy (Multis\u00adpec\u00adtral Optoa\u00adcou\u00adstic Tomo\u00adgra\u00adphy) for the detec\u00adtion of various dise\u00adase patterns such as cancer or fibro\u00adsis. Other inves\u00adtors in the Series D round with a total volume of EUR 13 million are TRUMPF Venture as lead inves\u00adtor, the Euro\u00adpean Inno\u00adva\u00adtion Coun\u00adcil Fund of the Euro\u00adpean Commis\u00adsion and the exis\u00adting inves\u00adtors Mey Capi\u00adtal Matrix, BayBG Baye\u00adri\u00adsche Betei\u00adli\u00adgungs\u00adge\u00adsell\u00adschaft mbH, Fluxu\u00adnit, Falk Stra\u00adscheg Holding and Occi\u00addent&nbsp;Group.<\/p>\n<p>In clini\u00adcal prac\u00adtice, a wide range of diagno\u00adstic proce\u00addu\u00adres is essen\u00adtial to diagnose dise\u00adase and moni\u00adtor response to treat\u00adment. In many areas, howe\u00adver, there is an unmet need for accu\u00adrate, objec\u00adtive, and quan\u00adti\u00adta\u00adtive methods.<\/p>\n<p>The unique multis\u00adpec\u00adtral optoa\u00adcou\u00adstic tomo\u00adgra\u00adphy (MSOT) from iThera Medi\u00adcal GmbH promi\u00adses a breakth\u00adrough here. The MedTech company was spun off from Helm\u00adholtz Zentrum M\u00fcnchen in 2010 with the aim of commer\u00adcia\u00adli\u00adzing rese\u00adarch results in the field of inno\u00adva\u00adtive medi\u00adcal imaging methods and today employs 45 people. iThera\u2019s MSOT tech\u00adno\u00adlogy uses the photoa\u00adcou\u00adstic effect \u2014 the conver\u00adsion of light energy into sound waves \u2014 to charac\u00adte\u00adrize and diffe\u00adren\u00adtiate diffe\u00adrent tissue types in the body and convert them into 3D images. In contrast to estab\u00adlished imaging methods, anato\u00admical, func\u00adtional and mole\u00adcu\u00adlar tissue infor\u00adma\u00adtion can thus be displayed for the first time at a depth of seve\u00adral centi\u00adme\u00adters in high reso\u00adlu\u00adtion. This enables physi\u00adci\u00adans to make diagno\u00adses early, non-inva\u00adsi\u00advely and in real time \u2014 for exam\u00adple in the case of vascu\u00adlar, fibro\u00adtic or tumor dise\u00ada\u00adses. MSOT has alre\u00adady demons\u00adtra\u00adted its poten\u00adtial clini\u00adcal value in a variety of studies and is curr\u00adently being used in clini\u00adcal rese\u00adarch at leading acade\u00admic hospi\u00adtals worldwide.<\/p>\n<p>The company will use the new funding to advance the tran\u00adsi\u00adtion of MSOT from rese\u00adarch to routine clini\u00adcal use. To this end, iThera Medi\u00adcal is deve\u00adlo\u00adping an MSOT device opti\u00admi\u00adzed for routine clini\u00adcal use in order to obtain regu\u00adla\u00adtory appr\u00adoval for use in Europe and the United States (CE and FDA appr\u00adoval) and to expand the clini\u00adcal evidence from previous studies.<\/p>\n<p>\u201cThe funding round is the next important step in taking our MSOT tech\u00adno\u00adlogy from a rese\u00adarch tool to a diagno\u00adstic tool in the clini\u00adcal setting, which we believe will be a game-chan\u00adger for milli\u00adons of pati\u00adents around the world,\u201d said <strong>Chris\u00adtian Wiest, CEO and co-foun\u00adder of iThera Medi\u00adcal<\/strong>. \u201cThe support of our inves\u00adtors \u2014 both new and exis\u00adting \u2014 will enable us to realize this vision.\u201d<\/p>\n<p><strong>Ulrich Kruse, Invest\u00adment Mana\u00adger at TRUMPF Venture  <\/strong>(photo), commen\u00adted, \u201ciThera Medi\u00adcal\u2019s tech\u00adno\u00adlogy is capa\u00adble of deli\u00adve\u00adring the next breakth\u00adrough in medi\u00adcal imaging. As a company with roots in photo\u00adnics and medi\u00adcal tech\u00adno\u00adlogy, we are plea\u00adsed to support MSOT\u2019s contin\u00adued deve\u00adlo\u00adp\u00adment and anti\u00adci\u00adpate a successful launch in medi\u00adcal imaging.\u201d<\/p>\n<p>\u201cMSOT addres\u00adses seve\u00adral criti\u00adcal limi\u00adta\u00adti\u00adons of today\u2019s non-inva\u00adsive in vivo imaging tech\u00adno\u00adlo\u00adgies, combi\u00adning the ease of use and depth pene\u00adtra\u00adtion of conven\u00adtio\u00adnal hand\u00adheld ultra\u00adsound systems with unpre\u00adce\u00adden\u00adted high-reso\u00adlu\u00adtion opti\u00adcal infor\u00adma\u00adtion down to the mole\u00adcu\u00adlar level,\u201d explai\u00adned <strong>Dr. Georg Ried, mana\u00adging direc\u00adtor of Bayern Kapi\u00adtal<\/strong>. \u201cThis will mini\u00admize risks for pati\u00adents and reduce finan\u00adcial burdens in seve\u00adral areas of health\u00adcare systems world\u00adwide. We are ther\u00ade\u00adfore very plea\u00adsed to conti\u00adnue on the path we have embarked on toge\u00adther in the future.\u201d<\/p>\n<p><strong>About iThera Medial:<\/strong><br>\nFoun\u00added in 2010, iThera Medi\u00adcal deve\u00adlops and markets optoa\u00adcou\u00adstic imaging systems for precli\u00adni\u00adcal and clini\u00adcal rese\u00adarch. More recently, the company has begun using its tech\u00adno\u00adlogy for routine clini\u00adcal diagno\u00adstics in a variety of dise\u00adase settings, inclu\u00adding cancer, inflamm\u00ada\u00adtion, fibro\u00adsis and cardio\u00advas\u00adcu\u00adlar dise\u00adase. Optoa\u00adcou\u00adstic imaging uses the photoa\u00adcou\u00adstic effect \u2014 the conver\u00adsion of light energy into acou\u00adstic signals \u2014 to visua\u00adlize and quan\u00adtify opti\u00adcal contrast in deep tissue with high spatial and tempo\u00adral resolution.<br>\n<a href=\"http:\/\/www.ithera-medical.com\/\" target=\"_blank\" rel=\"noopener\">www.ithera-medical.com<\/a><\/p>\n<p><strong>About Bayern Kapital:<\/strong><br>\nBayern Kapi\u00adtal GmbH, based in Lands\u00adhut, is the venture\/growth capi\u00adtal company of the Free State of Bava\u00adria. It accom\u00adpa\u00adnies inno\u00adva\u00adtive high-tech compa\u00adnies in the Free State through various growth phases, from seed to later stage, with equity capi\u00adtal in the amount of 0.25 to 25 million euros. Bayern Kapi\u00adtal often fills gaps in the VC sector in proven consor\u00adtium constel\u00adla\u00adti\u00adons with private inves\u00adtors (busi\u00adness angels, family offices and corpo\u00adrate ventures).<\/p>\n<p>Bayern Kapi\u00adtal mana\u00adges specia\u00adli\u00adzed invest\u00adment funds with a volume of around 700 million euros. Since its foun\u00adda\u00adtion in 1995 on the initia\u00adtive of the state govern\u00adment, the wholly owned subsi\u00addiary of LfA F\u00f6rder\u00adbank Bayern has so far inves\u00adted around 400 million euros of its own equity capi\u00adtal in around 300 start-ups and scale-ups in sectors such as life scien\u00adces, soft\u00adware &amp; IT, mate\u00adri\u00adals &amp; new mate\u00adri\u00adals, nano\u00adtech\u00adno\u00adlogy and envi\u00adron\u00admen\u00adtal tech\u00adno\u00adlogy. As a result, more than 8,000 jobs have been perma\u00adnently crea\u00adted in Bava\u00adria in sustainable compa\u00adnies. The active port\u00adfo\u00adlio curr\u00adently compri\u00adses over 80 companies.<\/p>\n<p>Examp\u00adles of nume\u00adrous ground\u00adbrea\u00adking success stories that Bayern Kapi\u00adtal has been invol\u00adved in early on include EOS (today the worl\u00add\u2019s leading tech\u00adno\u00adlogy provi\u00adder in indus\u00adtrial 3D prin\u00adting of metals and plas\u00adtics), Proglove, Fazua, SimS\u00adcale, Scom\u00adpler, egym, Parcel\u00adlab, Cobrai\u00adner, Quan\u00adtum Systems, Casavi, Theva, Riskme\u00adthods, Tubu\u00adlis, Cata\u00adlym, Immu\u00adnic, Sirion and many&nbsp;more.<br>\n<a href=\"http:\/\/www.bayernkapital.de\/\" target=\"_blank\" rel=\"noopener\">www.bayernkapital.de<\/a><\/p>\n<\/div>\n<div>\n<div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Landshut\/Munich \u2014 Bayern Kapi\u00adtal, one of the most expe\u00adri\u00aden\u00adced and active growth inves\u00adtors in the German high-tech land\u00adscape, is once again inves\u00adt\u00ading in iThera Medi\u00adcal with funds from the Bava\u00adrian Growth Fund. The Munich-based MedTech start-up is active in the field of optoa\u00adcou\u00adstic imaging for medi\u00adcal diagno\u00adstics and has deve\u00adlo\u00adped the laser light-based \u201cMSOT\u201d technology&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":47380,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1369,1373],"tags":[],"class_list":["post-47368","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-investors","category-venture-capital-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Series-D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Series-D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Landshut\/Munich \u2014 Bayern Kapi\u00adtal, one of the most expe\u00adri\u00aden\u00adced and active growth inves\u00adtors in the German high-tech land\u00adscape, is once again inves\u00adt\u00ading in iThera Medi\u00adcal with funds from the Bava\u00adrian Growth Fund. The Munich-based MedTech start-up is active in the field of optoa\u00adcou\u00adstic imaging for medi\u00adcal diagno\u00adstics and has deve\u00adlo\u00adped the laser light-based \u201cMSOT\u201d tech\u00adno\u00adlogy [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-21T10:50:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1104\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Series\u2011D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical\",\"datePublished\":\"2022-12-21T10:50:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/\"},\"wordCount\":870,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Investors\",\"Venture Capital\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/\",\"url\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/\",\"name\":\"Series-D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg\",\"datePublished\":\"2022-12-21T10:50:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg\",\"width\":1104,\"height\":811},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Series\u2011D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Series-D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/","og_locale":"en_US","og_type":"article","og_title":"Series-D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical - FYB Financial Yearbook","og_description":"Landshut\/Munich \u2014 Bayern Kapi\u00adtal, one of the most expe\u00adri\u00aden\u00adced and active growth inves\u00adtors in the German high-tech land\u00adscape, is once again inves\u00adt\u00ading in iThera Medi\u00adcal with funds from the Bava\u00adrian Growth Fund. The Munich-based MedTech start-up is active in the field of optoa\u00adcou\u00adstic imaging for medi\u00adcal diagno\u00adstics and has deve\u00adlo\u00adped the laser light-based \u201cMSOT\u201d tech\u00adno\u00adlogy [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2022-12-21T10:50:55+00:00","og_image":[{"width":1104,"height":811,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Series\u2011D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical","datePublished":"2022-12-21T10:50:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/"},"wordCount":870,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg","articleSection":["General","Featured","News","Investors","Venture Capital"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/","url":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/","name":"Series-D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg","datePublished":"2022-12-21T10:50:55+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/12\/csm-trumpf-venture-kruse-1.jpeg","width":1104,"height":811},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/series-d-over-e-13-million-bayern-kapital-invests-again-in-ithera-medical\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Series\u2011D over \u20ac 13 million: Bayern Kapital invests again in iThera Medical"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/47368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=47368"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/47368\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/47380"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=47368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=47368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=47368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}